Emvision Medical Devices Ltd. · ASX:EMV
Emvision Medical Devices — Technical Presentation (October 2026)
11 slides from Emvision Medical Devices's technical presentation, Oct 19, 2026
Slide 1: Mayo Clinic emu Early Clinical Experience Presentation
19/10/2026 EMVision Medical Devices Ltd ACN 620 388 230 Suite 4.01, 65 Epping Rd Sydney NSW 2113 02 8667 5337 For personal use only contact@emvision.com.au MAYO CLINIC emu™ EARLY CLINICAL EXPERIENCE PRESENTATION EMVision Medical Devices Limited (ASX:EMV) (“EMVision” or the “Company”) is pleased to r
Slide 2: Clinical Investigation Summary
Clinical Investigation Summary Trial sites are activated in a staggered manner. For personal use only Study Title The EMU Study Investigational Leading Research Institutions and Comprehensive Stroke Centres in Site the United States and Australia Design of the Multi-Centre, Prospective, Consecutive,
Slide 3: About EMVision Medical Devices
About EMVision Medical Devices EMVision Medical Devices Limited (ASX:EMV) is an innovative Australian medical device company developing a novel approach to looking inside the human body. Our product pipeline includes portable, non- invasive, affordable and safe neurodiagnostic devices. For personal
Slide 4: Portable Radiofrequency Brain Scanner Early Clinical Experience
rsonal use only PORTABLE RADIOFREQUENCY BRAIN SCANNER EARLY CLINICAL EXPERIENCE EARLY IMPLEMENTATION EXPERIENCE INTO EMERGENCY CODE STROKE WORKFLOW Presented By: Yelim Lee Co-PIs: Dr. David Freeman Dr. Leslie Simon ©2026 Mayo Foundation for Medical Education and Research | WF1197406-1
Slide 5: Introduction/Hypothesis
INTRODUCTION/HYPOTHESIS rsonal use only Technology Brain Scanner Status: Investigational Device Non-ionizing radiation using ultra-high ~220 lbs frequency radio waves (500-2000MHz) Portable Dielectric property contrast (conductivity In-hospital and permittivity) cause scan signals to reflect Non-ion
Slide 6: Preliminary Performance Testing
PRELIMINARY PERFORMANCE TESTING • Earlier Multi-centre Australian study (EMView) enrolled 307 participants including 277 suspected strokes (48 rsonal use only ICH and 140 confirmed ischaemic strokes), ~75% of data used for training and ~25% used for unseen testing ‘Hemorrhage (bleed) or not’ ‘Ischem
Slide 7: Methods
METHODS United States Sites Memorial Hermann-Texas Medical Center Mayo Clinic Florida Mount Sinai Hospital Ronald Reagan UCLA Medical Center rsonal use only Multi-Centre, Prospective, Consecutive, Paired Diagnosis, Design Diagnostic Performance Study Network Sites Mount Sinai West Objective Demonstr
Slide 8: Methods
METHODS Common Scan Opportunities: rsonal use only - During stroke team assessment - Waiting CT availability Each scan 10 Minutes ©2026 Mayo Foundation for Medical Education and Research | WF1197406-5
Slide 9: Results
RESULTS Scanner placed in ED alcove rsonal use only in front of CT suite - Compatible with busy ED workflow - Operated by nurses, clinicians - Operator training ≅ 1 hour - Scan success in majority of cases - No device related adverse events Key Challenges: - Agitated patients due to their condition
Slide 10: Conclusion
CONCLUSION Compatible with emergency code stroke workflow rsonal use only Prospective Multicenter Study Study progressing rapidly with active enrolment across participating centers 33+ total participants enrolled at Mayo Clinic Jacksonville, FL 230+ total participants enrolled internationally (the m
Slide 11: Questions & Discussion
rsonal use only QUESTIONS & DISCUSSION ©2026 Mayo Foundation for Medical Education and Research | WF1197406-8
EMVision Medical Devices — Technical Presentation (October 2026) on 6ix